Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Applying to Johns Hopkins University/Sidney Kimmel Cancer Center · Baltimore, Maryland
Answer a few short questions to share with the research team.